Speciality: Cardiographer band 3
Location: West Midlands
Duration: Temporary
Speciality: Respiratory Physiologist
Location: London
Duration: Temporary
Speciality: BSE Echocardiographer
Location: North East England
Duration: Temporary
Speciality: Respiratory Physiologist
Location: South East Coast
Duration: Temporary
The production of highly functional new blood cells could be stimulated in oxygen-starved tissues, research has revealed.
A study, published online in Nature Biotechnology, found that if a biological factor, known as fibroblast growth factor 9 (FGF9), is delivered at the same time the body is trying to form new blood vessels in damaged tissue, it becomes a successful attempt.
Dr Pickering, of the Robarts Research Institute, indicated that the discovery could be used in cardiac patients.
"Coronary bypass surgery and stenting are important treatments but are not suitable for many individuals," he said.
"Because of this, there has been considerable interest in recent years in developing biological strategies that promote the regeneration of a patient's own blood vessels."
This follows news that a promising blood thinning drug known as Dabigatran etexilate could lessen the risk of stroke in atrial fibrillation patients.
The drug, known as Pradaxa, could change the lives of people with heart rhythm disorders, after research found that the medication cut the risk of stroke by between 30 and 39 per cent.
Written by Angela Newbury
As many as one per cent of children are born with congenital heart disease, but in many cases the cause of this...
Cardiac rehabilitation (CR) is an intervention - typically offered to people diagnosed with either heart disease...
Hypertrophic cardiomyopathy (HCM), an inherited heart condition affecting one person out of every 500 worldwide,...
While there are certain life elements that can lead to someone becoming predisposed to cardiovascular disease...